Doxorubicin pathways: pharmacodynamics and adverse effects.
Departments of Genetics, Stanford University Medical Center, California 94305-5120, USA.
Caroline F
CF
Thorn
Connie
C
Oshiro
Sharon
S
Marsh
Tina
T
Hernandez-Boussard
Howard
H
McLeod
Teri E
TE
Klein
Russ B
RB
Altman
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000494:pharmacology*; D004317:Doxorubicin / Q000009:adverse effects* / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007364:Intercalating Agents / Q000009:adverse effects* / Q000494:pharmacology*; D010597:Pharmacogenetics; D010641:Phenotype; D011110:Polymorphism, Genetic
D000903:Antibiotics, Antineoplastic; D007364:Intercalating Agents; D004317:Doxorubicin